BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rethinking Clinical Trials - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://rethinkingclinicaltrials.org
X-WR-CALDESC:Events for Rethinking Clinical Trials
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180319T130000
DTEND;TZID=America/New_York:20180319T170000
DTSTAMP:20260530T154300
CREATED:20180228T170733Z
LAST-MODIFIED:20180228T171029Z
UID:10130-1521464400-1521478800@rethinkingclinicaltrials.org
SUMMARY:March 19: OHDSI: FDA Workshop: Developing & Submitting Proposed Draft Guidance on Patient Experience Data
DESCRIPTION:Topic: FDA Workshop: Developing & Submitting Proposed Draft Guidance on Patient Experience Data \nThe purpose of this public workshop is to obtain input from stakeholders on considerations for development and submission of proposed draft guidance relating to patient experience data submitted by an external stakeholder\, including: \n\nDefining the scope of the proposed draft guidance\nDeveloping the proposed draft guidance\nSubmitting the proposed draft guidance to the FDA\n\nDate: Monday\, March 19\, 2018\, 1:00-2:00 p.m. ET \nLocation:  \nFDA White Oak Campus\n10903 New Hampshire Avenue\nBuilding 31\, Room 1503 (Great Room)\nSilver Spring\, MD 20993\n(Information about arrival to FDA’s White Oak campus) \nRegistration:\nRegister here \nRegistration to attend in person will close on March 12\, 2018. \nIf you are unable to attend the workshop in person\, you can register to view a live webcast of the workshop. You will be asked to indicate in your registration if you plan to attend in person or via the webcast. Seating will be limited\, so early registration is recommended. Registration is free and will be on a first-come\, first-served basis. However\, FDA may limit the number of participants from each organization based on space limitations. Registrants will receive confirmation once they have been accepted. Onsite registration on the day of the workshop will be based on space availability.
URL:https://rethinkingclinicaltrials.org/event/march-19-ohdsi-fda-workshop-developing-submitting-proposed-draft-guidance-on-patient-experience-data/
END:VEVENT
END:VCALENDAR